Topo CRISPR Plasmids
산타크루즈바이오테크놀러지는 광범위한 유전자침묵제품 CRISPR/Cas9 Knockout와 CRISPR Double Nickase plasmids를 제공합니다. Topo유전자침묵제품인 Topo CRISPR/Cas9 Knockout plasmids와 Topo Double Nickase Plasmids를 제공합니다. 유전자 활성화제품인Topo CRISPR/dCas9 Activation Plasmids와 CRISPR Lenti Activation Systems를 제공합니다. 유전자침묵과 활성화제품은 항체와 함께 사용하면 프로틴검출의 연구에 유용하게 사용할수있습니다.
Topo CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
Topo I CRISPR/Cas9 케이오 플라스미드 (h) | sc-400965 | h | Gene Knockout | GFP | 0 | ||
Topo I HDR Plasmid (h) | sc-400965-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Topo I Double Nickase Plasmid (h) | sc-400965-NIC | h | Gene Knockout | Puromycin | 0 | ||
Topo I Double Nickase Plasmid (h2) | sc-400965-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Topo I CRISPR/Cas9 케이오 플라스미드 (m) | sc-423468 | m | Gene Knockout | GFP | 0 | ||
Topo I HDR 플라스미드 (m) | sc-423468-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
Topo I 더블 틈내기효소 플라스미드 (m) | sc-423468-NIC | m | Gene Knockout | Puromycin | 0 | ||
Topo I 더블 틈내기효소 플라스미드 (m2) | sc-423468-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Topo IIα CRISPR/Cas9 케이오 플라스미드 (h) | sc-400869 | h | Gene Knockout | GFP | 1 | ||
Topo IIα HDR 플라스미드 (h) | sc-400869-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
Topo IIα 더블 틈내기효소 플라스미드 (h) | sc-400869-NIC | h | Gene Knockout | Puromycin | 1 | ||
Topo IIα 더블 틈내기효소 플라스미드 (h2) | sc-400869-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
Topo IIα CRISPR/Cas9 케이오 플라스미드 (m) | sc-423469 | m | Gene Knockout | GFP | 1 | ||
Topo IIα HDR 플라스미드 (m) | sc-423469-HDR | m | Homology Directed Repair | Puromycin | 1 | ||
Topo IIα 더블 틈내기효소 플라스미드 (m) | sc-423469-NIC | m | Gene Knockout | Puromycin | 1 | ||
Topo IIα 더블 틈내기효소 플라스미드 (m2) | sc-423469-NIC-2 | m | Gene Knockout | Puromycin | 1 | ||
Topo IIβ CRISPR/Cas9 케이오 플라스미드 (h) | sc-400773 | h | Gene Knockout | GFP | 0 | ||
Topo IIβ HDR Plasmid (h) | sc-400773-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Topo IIβ Double Nickase Plasmid (h) | sc-400773-NIC | h | Gene Knockout | Puromycin | 0 | ||
Topo IIβ Double Nickase Plasmid (h2) | sc-400773-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Topo IIβ CRISPR/Cas9 케이오 플라스미드 (m) | sc-423470 | m | Gene Knockout | GFP | 1 | ||
Topo IIβ HDR 플라스미드 (m) | sc-423470-HDR | m | Homology Directed Repair | Puromycin | 1 | ||
Topo IIβ 더블 틈내기효소 플라스미드 (m) | sc-423470-NIC | m | Gene Knockout | Puromycin | 1 | ||
Topo IIβ 더블 틈내기효소 플라스미드 (m2) | sc-423470-NIC-2 | m | Gene Knockout | Puromycin | 1 | ||
Topo IIIα CRISPR/Cas9 케이오 플라스미드 (h) | sc-404439 | h | Gene Knockout | GFP | 0 | ||
Topo IIIα HDR 플라스미드 (h) | sc-404439-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
Topo IIIα 더블 틈내기효소 플라스미드 (h) | sc-404439-NIC | h | Gene Knockout | Puromycin | 0 | ||
Topo IIIα 더블 틈내기효소 플라스미드 (h2) | sc-404439-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Topo IIIα CRISPR/Cas9 케이오 플라스미드 (m) | sc-423471 | m | Gene Knockout | GFP | 0 | ||
Topo IIIα 더블 틈내기효소 플라스미드 (m) | sc-423471-NIC | m | Gene Knockout | Puromycin | 0 | ||
Topo IIIα 더블 틈내기효소 플라스미드 (m2) | sc-423471-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
Topo IIIβ CRISPR/Cas9 케이오 플라스미드 (h) | sc-406840 | h | Gene Knockout | GFP | 0 | ||
Topo IIIβ 더블 틈내기효소 플라스미드 (h) | sc-406840-NIC | h | Gene Knockout | Puromycin | 0 | ||
Topo IIIβ 더블 틈내기효소 플라스미드 (h2) | sc-406840-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
Topo IIIβ CRISPR/Cas9 케이오 플라스미드 (m) | sc-423472 | m | Gene Knockout | GFP | 0 | ||
Topo IIIβ CRISPR/Cas9 케이오 플라스미드 (m) | sc-423472-KO-2 | m | Gene Knockout | GFP | 0 | ||
Topo IIIβ HDR 플라스미드 (m2) | sc-423472-HDR-2 | m | Homology Directed Repair | Puromycin | 0 | ||
Topo IIIβ 더블 틈내기효소 플라스미드 (m) | sc-423472-NIC | m | Gene Knockout | Puromycin | 0 | ||
Topo IIIβ 더블 틈내기효소 플라스미드 (m2) | sc-423472-NIC-2 | m | Gene Knockout | Puromycin | 0 |
Topo CRISPR Activation Products
| Empty Table Header | 제품명 | 카탈로그# | Species | APPLICATIONS | MARKER | 引用 | RATING |
|---|---|---|---|---|---|---|---|
Topo I CRISPR Activation Plasmid (h) | sc-400965-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo I CRISPR Activation Plasmid (h2) | sc-400965-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo I Lentiviral Activation Particles (h) | sc-400965-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo I Lentiviral Activation Particles (h2) | sc-400965-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo I CRISPR 활성화 플라스미드(m) | sc-423468-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo I CRISPR 활성화 플라스미드(m2) | sc-423468-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo I 렌티바이러스의 활성화 입자 (m) | sc-423468-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo I 렌티바이러스의 활성화 입자 (m2) | sc-423468-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIα CRISPR 활성화 플라스미드(h) | sc-400869-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIα CRISPR 활성화 플라스미드(h2) | sc-400869-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIα 렌티바이러스의 활성화 입자 (h) | sc-400869-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIα 렌티바이러스의 활성화 입자 (h2) | sc-400869-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIα CRISPR 활성화 플라스미드(m) | sc-423469-ACT | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIα CRISPR 활성화 플라스미드(m2) | sc-423469-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIα 렌티바이러스의 활성화 입자 (m) | sc-423469-LAC | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIα 렌티바이러스의 활성화 입자 (m2) | sc-423469-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIβ CRISPR Activation Plasmid (h) | sc-400773-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIβ CRISPR Activation Plasmid (h2) | sc-400773-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIβ Lentiviral Activation Particles (h) | sc-400773-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIβ Lentiviral Activation Particles (h2) | sc-400773-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIβ CRISPR 활성화 플라스미드(m) | sc-423470-ACT | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIβ CRISPR 활성화 플라스미드(m2) | sc-423470-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIβ 렌티바이러스의 활성화 입자 (m) | sc-423470-LAC | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIβ 렌티바이러스의 활성화 입자 (m2) | sc-423470-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 1 | ||
Topo IIIα CRISPR 활성화 플라스미드(h) | sc-404439-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIα CRISPR 활성화 플라스미드(h2) | sc-404439-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIα 렌티바이러스의 활성화 입자 (h) | sc-404439-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIα 렌티바이러스의 활성화 입자 (h2) | sc-404439-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIα CRISPR 활성화 플라스미드(m) | sc-423471-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIα CRISPR 활성화 플라스미드(m2) | sc-423471-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIα 렌티바이러스의 활성화 입자 (m) | sc-423471-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIα 렌티바이러스의 활성화 입자 (m2) | sc-423471-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIβ CRISPR 활성화 플라스미드(h) | sc-406840-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIβ CRISPR 활성화 플라스미드(h2) | sc-406840-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIβ 렌티바이러스의 활성화 입자 (h) | sc-406840-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIβ 렌티바이러스의 활성화 입자 (h2) | sc-406840-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIβ CRISPR 활성화 플라스미드(m) | sc-423472-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIβ CRISPR 활성화 플라스미드(m2) | sc-423472-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIβ 렌티바이러스의 활성화 입자 (m) | sc-423472-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
Topo IIIβ 렌티바이러스의 활성화 입자 (m2) | sc-423472-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |